A comparison of latanoprost monotherapy with a combination therapy of timolol/dorzolamide in patients with primary open-angle glaucoma

dc.contributor.authorCaca, Ihsan
dc.contributor.authorSimsek, Hueseyin
dc.contributor.authorUenlue, Kaan
dc.contributor.authorAri, Seyhmus
dc.contributor.authorKeklikci, Ugur
dc.date.accessioned2024-04-24T17:17:55Z
dc.date.available2024-04-24T17:17:55Z
dc.date.issued2006
dc.departmentDicle Üniversitesien_US
dc.description.abstractWe compared latanoprost monotherapy therapy with timolol/dorzolamide in patients with primary open-angle glaucoma to evaluate the effects on intraocular pressure (IOP) and occurrence of adverse events. IOP and topical side, effects were evaluated at the begining, first, and third months. Mean IOP was decreased at the third month. The most common side effect was hyperemia (43.6%). We Concluded that latanoprost reduces IOP better than fixed combination and its topical side effects are tolerable.en_US
dc.identifier.doi10.1385/AO:38:2:111
dc.identifier.endpage115en_US
dc.identifier.issn1530-4086
dc.identifier.issue2en_US
dc.identifier.pmid17416939
dc.identifier.scopus2-s2.0-33749139972
dc.identifier.scopusqualityN/A
dc.identifier.startpage111en_US
dc.identifier.urihttps://doi.org/10.1385/AO:38:2:111
dc.identifier.urihttps://hdl.handle.net/11468/18439
dc.identifier.volume38en_US
dc.identifier.wosWOS:000203335400006
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherAmer Soc Contemporary Medicine Surgery & Ophthalmologyen_US
dc.relation.ispartofAnnals of Ophthalmology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleA comparison of latanoprost monotherapy with a combination therapy of timolol/dorzolamide in patients with primary open-angle glaucomaen_US
dc.titleA comparison of latanoprost monotherapy with a combination therapy of timolol/dorzolamide in patients with primary open-angle glaucoma
dc.typeArticleen_US

Dosyalar